68-2

79/110

) Hu A, Gu Y, Yamaguchi T, Liu H, Uehara Y, Ui M, Okuno S, Watanabe D, Mizushima S, Feng Q, Xia S, Mizushima A: Identified of Potential Therapeutic Targets for Salivary Gland Adenoid Cystic Carcinoma by Bioin‑formatic Analysis. MedLife Clinics, 2019; 1: 41-49.) Miura T, Matsumoto Y, Kawaguchi T, Masuda Y, Okizaki A, Koga H, Tagami K, Sumazaki Watanabe Y, Uehara Y, Yamaguchi T, Morita T: Low Phase Angle Is Correlated With Worse General Condition in Patients with Advanced Cancer. Nutrition and cancer, 2019; 71: 83-88.) Gu Y, Feng Q, Liu H, Zhou Q, Hu A, Yama‑guchi T, Xia S, Kobayashi H: Bioinformatic evidences and analysis of putative biomarkers in pancreatic ductal adenocarcinoma. Heliyon, 2019; 5: e02378. doi: 10.1016/j.heliyon.2019.e02378.〈Reviews〉 1) Hino O, Abe M, Han B, Yan Y: In commemo‑ration of the 2018 Mataro Nagayo Prize: A road to early diagnosis and monitoring of asbestos-related mesothelioma. Cancer Science, 2019; 110: 1518-1524.) Shi-Lin Xia, Liu H, Mizushima S, Mizushima A: A clue to potential therapeutic targets: application of integrative medicine and bioin‑formatics. Drug Combination Therapy, 2019; Vol.1: 165-172. doi: 10.12032/DCT201903004 ) Imai-Okazaki A, Kishita Y, Kohda M, Mizuno 132-140.) Kato S, Hayashi T, Suehara Y, Hamanoue H, Yamanaka S, Ichikawa Y, Higurashi T, Ohashi K, Yamaguchi S, Nozaki Y, Terao Y, Saito T, Yao T, Nakajima A, Syed Aijazuddin, Zehir Ahmet, Ladanyi, Marc, Kato S: Multicenter Experience With Large Panel Next-Genera‑tion Sequencing in Patients With Advanced Solid Cancers in Japan. Jpn J Clin Oncol, 2019; 49: 174-182. 2Palliative Medicine〈Original Articles〉 1 2 3 2Diagnostics and Therapeutics of Intractable Diseases〈Original Articles〉 1 3＊ 4) Nomura H, Sekine M, Yokoyama S, Arai M, Enomoto T, Takeshima N, Nakamura S: Clin‑ical background and outcomes of risk-re‑ducing salpingo-oophorectomy for heredi‑tary breast and ovarian cancers in Japan. Int J Clin Oncol, 2019; 24: 1105-1110.) Hirono K, Ichida F, Nishio N, Ogawa-Tominaga M, Fushimi T, Feichtinger RG, Mayr JA, Kohda M, Kishita Y, Okazaki Y, Ohtake A, Murayama K: Mitochondrial complex defi‑ciency by novel compound heterozygous TMEM70 variants and correlation with developmental delay, undescended testicle, and left ventricular noncompaction in a Japa‑nese patient: A case report. Clin Case Rep, 2019; 7: 553-557. ) Hisatomi Y, Murayama K, Ohtake A, Okazaki Y: Reply to the “Letter to the Editor” from Dr. J Finsterer and colleagues. Neurogenetics, 2019; 20: 55-56. ) Horimoto Y, Terao T, Tsutsumi Y, Tanabe M, Mogushi K, Hiaing MT, Sasaki R, Saeki H, Okazaki M, Sonoue H, Arakawa A, Saito M: Estrogen Receptor-positive Ductal Carcinoma In Situ Frequently Overexpresses HER2 Protein Without Gene Amplification. Am J Surg Pathol, 2019; 43: 1221-1228.) Subat S, Mogushi K, Yasen M, Kohda T, Ishi‑kawa Y, Tanaka H: Identification of genes and pathways, including the CXCL2 axis, 5 6 7 8Y, Fushimi T, Matsunaga A, Yatsuka Y, Hirata T, Harashima H, Takeda A, Nakaya A, Sakata Y, Kogaki S, Ohtake A, Murayama K, Okazaki Y: Cardiomyopathy in children with mitochondrial disease: Prognosis and genetic background. Int J Cardiol, 2019; 279: 115-121.† 2) Borna NN, Kishita Y, Kohda M, Li SC, Shimura M, Wu Y, Mogushi K, Yatsuka Y, Harashima H, Hisatomi Y, Fushimi T, Ichimoto K, Murayama K, Ohtake, Okazaki Y: Mitochondrial ribosomal protein PTCD3 mutations cause oxidative phosphorylation defects with Leigh syndrome. Neurogenetics, 2019; 20: 9-25.) Fink J, Schoenfeld BJ, Hackney AC, Matsu‑moto M, Maekawa T, Nakazato K, Horie S: Anabolic-androgenic steroids: procurement and administration practices ofdoping athletes. Phys Sportsmed, 2019; 47: 10-14. 171